2023_Oct_PODD_Boston_Leaderboard

Bespak by Recipharm

Bespak by Recipharm supplies pulmonary and nasal delivery devices, valves and actuators, injectable devices and medical check valves into major markets. As a high-volume manufacturer, each year it moulds around 2.6 billion components which are assembled into approximately 550 million devices.

Associated Companies

Recipharm

Headquarters
Bespak by Recipharm
Bergen Way
King’s Lynn
Norfolk
PE30 2JJ
United Kingdom

Phone / Contact

T: +44 1553 691000
F: +44 1553 693728
E: [email protected]

Connect

Bespak by Recipharm, was a brand of CDMO Recipharm, formed when Recipharm acquired Bespak in 2020. It has since been fully absorbed into the Advanced Drug Delivery Systems business area of Recipharm.

Articles by Bespak by Recipharm

CONNECTING PATIENTS AND HEALTHCARE PROVIDERS IN THE AGE OF SELF-ADMINISTERED INJECTABLE DRUGS

Gemma Wood explores connected device development trends, the patient-centric benefits the technology has to offer and how, with the help of experienced manufacturing partners connected to key enabling technology partners, they can develop products that deliver improved patient outcomes.

Dr Andrew Donnelly

ADDRESSING THE CHALLENGES OF VISCOUS INJECTABLE ADMINISTRATION

Andrew Donnelly and Shahid Uddin look at the challenges of self-administration of injectable viscous formulations and the technology that is helping to overcome these issues.

THE CHANGING FACE OF AUTOINJECTOR TECHNOLOGY

Reenal Gandhi discusses the advantages offered by liquefied gas as a power source for autoinjectors compared with conventional spring-based systems, as well as covering the benefits of using a platform model for drug delivery device development.

PAUL ALLSOP, MILES KOTTMAN, HANNAH PRIESTLY & JON REED, CONSORT GROUP

Consort Medical's Paul Allsop, Miles Kottman, Hannah Priestly and Jon Reed talk with ONdrugDelivery Magazine about the company’s integrated formulation and device offering, and focus on its simple, low-cost, single unit-dose, spring powered nasal device, Unidose Xtra.

MEETING FUTURE NEEDS FOR RESPIRATORY DRUG DELIVERY DEVELOPMENT

Mark Knowles and Collette Johnson explore the different elements that need to be considered when developing a smart inhalation drug delivery device to ensure that maximum benefit is obtained.

STEVEN R KAUFMAN, BESPAK

Steven Kaufman is Global Business Development Lead at Bespak Europe Ltd, responsible for business development activities related to injectable devices such as auto-injectors and wearable injection systems.

Top